Serum ghrelin level in women with polycystic ovary syndrome and its relationship with endocrine and metabolic parameters

References

• Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656–660
   PubMed Web of Science ®Google Scholar
• Otto B, Spranger J, Benoit S C, Clegg D J, Tschop M H. The many faces of ghrelin: new perspectives for nutrition research. Br J Nutr 2005; 93: 765–771
   Google Scholar
• Ghigo E, Broglio F, Arvat E, Maccario M, Papotti M, Muccioli G. Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor. Clin Endocrinol (Oxf) 2005; 62: 1–17
   PubMed Web of Science ®Google Scholar
• Tschop M, Weyer C, Tataranni P A, Devanarayan V, Ravussin E, Heiman M L. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001; 50: 707–709
   PubMed Web of Science ®Google Scholar
• Poykko S M, Kellokoski E, Horkko S, Kauma H, Kesaniemi Y A, Ukkola O. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 2003; 52: 2546–2553
   PubMed Web of Science ®Google Scholar
• Guido M, Romualdi D, De Marinis L, Porcelli T, Giuliani M, Costantini B, Lanzone A. Administration of exogenous ghrelin in obese patients with polycystic ovary syndrome: effects on plasma levels of growth hormone, glucose, and insulin. Fertil Steril 2007; 88: 125–130
   Google Scholar
• Schaller G, Schmidt A, Pleiner J, Woloszczuk W, Wolzt M, Luger A. Plasma ghrelin concentrations are not regulated by glucose or insulin: a double-blind, placebo-controlled crossover clamp study. Diabetes 2003; 52: 16–20
   PubMed Web of Science ®Google Scholar
• Lucidi P, Murdolo G, Di Loreto C, De Cicco A, Parlanti N, Fanelli C, Santeusanio F, Bolli G B, De Feo P. Ghrelin is not necessary for adequate hormonal counterregulation of insulin-induced hypoglycemia. Diabetes 2002; 51: 2911–2914
   PubMed Web of Science ®Google Scholar
• McLaughlin T, Abbasi F, Lamendola C, Frayo R S, Cummings D E. Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls. J Clin Endocrinol Metab 2004; 89: 1630–1635
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E. Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications. Expert Rev Mol Med 2008; 10: e3
   PubMedGoogle Scholar
• Pasquali R, Gambineri A, Pagotto U. The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG 2006; 113: 1148–1159
   PubMed Web of Science ®Google Scholar
• Pagotto U, Gambineri A, Vicennati V, Heiman M L, Tschop M, Pasquali R. Plasma ghrelin, obesity, and the polycystic ovary syndrome, correlation with insulin resistance and androgen levels. J Clin Endocrinol Metab 2002; 87: 5625–5629
   PubMed Web of Science ®Google Scholar
• Panidis D, Farmakiotis D, Koliakos G, Rousso D, Kourtis A, Katsikis I, Asteriadis C, Karayannis V, Diamanti-Kandarakis E. Comparative study of plasma ghrelin levels in women with polycystic ovary syndrome, in hyperandrogenic women and in normal controls. Hum Reprod 2005; 20: 2127–2132
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Christakou C, Kandarakis H. Polycystic ovarian syndrome: the commonest cause of hyperandrogenemia in women as a risk factor for metabolic syndrome. Minerva Endocrinol 2007; 32: 35–47
   PubMedGoogle Scholar
• Rizzo M, Rini G B, Carmina E. Androgen excess and cardiovascular risk. Minerva Endocrinol 2007; 32: 67–71
   Google Scholar
• Schofl C, Horn R, Schill T, Schlosser H W, Muller M J, Brabant G. Circulating ghrelin levels in patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2002; 87: 4607–4610
   PubMed Web of Science ®Google Scholar
• Moran L J, Noakes M, Clifton P M, Wittert G A, Tomlinson L, Galletly C, Luscombe N D, Norman R J. Ghrelin and measures of satiety are altered in polycystic ovary syndrome but not differentially affected by diet composition. J Clin Endocrinol Metab 2004; 89: 3337–3344
   PubMed Web of Science ®Google Scholar
• Micic D, Sumarac-Dumanovic M, Kendereski A, Cvijovic G, Zoric S, Pejkovic D, Micic J, Milic N, Dieguez C, Casanueva F F. Total ghrelin levels during acute insulin infusion in patients with polycystic ovary syndrome. J Endocrinol Invest 2007; 30: 820–827
   PubMed Web of Science ®Google Scholar
• Wasko R, Komarowska H, Warenik-Szymankiewicz A, Sowinski J. Elevated ghrelin plasma levels in patients with polycystic ovary syndrome. Horm Metab Res 2004; 36: 170–173
   PubMed Web of Science ®Google Scholar
• Orio F, Jr, Lucidi P, Palomba S, Tauchmanova L, Cascella T, Russo T, Zullo F, Colao A, Lombardi G, De Feo P. Circulating ghrelin concentrations in the polycystic ovary syndrome. J Clin Endocrinol Metab 2003; 88: 942–945
   PubMed Web of Science ®Google Scholar
• Bik W, Baranowska-Bik A, Wolinska-Witort E, Chmielowska M, Martynska L, Baranowska B. The relationship between metabolic status and levels of adiponectin and ghrelin in lean women with polycystic ovary syndrome. Gynecol Endocrinol 2007; 23: 325–331
   PubMed Web of Science ®Google Scholar
• The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81: 19–25
   Web of Science ®Google Scholar
• Hosoda H, Doi K, Nagaya N, Okumura H, Nakagawa E, Enomoto M, Ono F, Kangawa K. Optimum collection and storage conditions for ghrelin measurements: octanoyl modification of ghrelin is rapidly hydrolyzed to desacyl ghrelin in blood samples. Clin Chem 2004; 50: 1077–1080
   PubMed Web of Science ®Google Scholar
• Garcia M C, Lopez M, Alvarez C V, Casanueva F, Tena-Sempere M, Dieguez C. Role of ghrelin in reproduction. Reproduction 2007; 133: 531–540
   PubMed Web of Science ®Google Scholar
• Makovey J, Naganathan V, Seibel M, Sambrook P. Gender differences in plasma ghrelin and its relations to body composition and bone – an opposite-sex twin study. Clin Endocrinol (Oxf) 2007; 66: 530–537
   PubMed Web of Science ®Google Scholar
• Kajaia N, Binder H, Dittrich R, Oppelt P G, Flor B, Cupisti S, Beckmann M W, Mueller A. Low sex hormone-binding globulin as a predictive marker for insulin resistance in women with hyperandrogenic syndrome. Eur J Endocrinol 2007; 157: 499–507
   Google Scholar
• Gosman G G, Katcher H I, Legro R S. Obesity and the role of gut and adipose hormones in female reproduction. Hum Reprod Update 2006; 12: 585–601
   PubMed Web of Science ®Google Scholar
• Soriano-Guillen L, Barrios V, Campos-Barros A, Argente J. Ghrelin levels in obesity and anorexia nervosa: effect of weight reduction or recuperation. J Pediatr 2004; 144: 36–42
   PubMed Web of Science ®Google Scholar
• Kasim-Karakas S E, Cunningham W M, Tsodikov A. Relation of nutrients and hormones in polycystic ovary syndrome. Am J Clin Nutr 2007; 85: 688–694
   Google Scholar
• Klok M D, Jakobsdottir S, Drent M L. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes Rev 2007; 8: 21–34
   PubMed Web of Science ®Google Scholar
• Ikezaki A, Hosoda H, Ito K, Iwama S, Miura N, Matsuoka H, Kondo C, Kojima M, Kangawa K, Sugihara S. Fasting plasma ghrelin levels are negatively correlated with insulin resistance and PAI-1, but not with leptin, in obese children and adolescents. Diabetes 2002; 51: 3408–3411
   PubMed Web of Science ®Google Scholar
• Cummings D E, Purnell J Q, Frayo R S, Schmidova K, Wisse B E, Weigle D S. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001; 50: 1714–1719
   PubMed Web of Science ®Google Scholar
• Chan J L, Bullen J, Lee J H, Yiannakouris N, Mantzoros C S. Ghrelin levels are not regulated by recombinant leptin administration and/or three days of fasting in healthy subjects. J Clin Endocrinol Metab 2004; 89: 335–343
   PubMed Web of Science ®Google Scholar
• Fusco A, Bianchi A, Mancini A, Milardi D, Giampietro A, Cimino V, Porcelli T, Romualdi D, Guido M, Lanzone A, et al. Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome. J Endocrinol Invest 2007; 30: 948–956
   Google Scholar